(Q41655592)

6 October 2017

title

Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirus (English)

1 reference

6 October 2017

0 references

6

E De Clercq

0 references

Dominique Schols

object named as

D Schols

3

0 references

Graciela Andrei

object named as

G Andrei

1

0 references

Robert Snoeck

object named as

R Snoeck

2

0 references

author name string

P Goubau

4

1 reference

6 October 2017

J Desmyter

5

1 reference

6 October 2017

E De Clercq

6

1 reference

6 October 2017

publication date

1 December 1991

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

6 October 2017

published in

1 reference

6 October 2017

volume

10

1 reference

6 October 2017

issue

12

1 reference

6 October 2017

page(s)

1026-1033

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01984924

6 October 2017

exact match

0 references

cites work

Cytomegalovirus and the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF01984924

Intravenous foscarnet for the treatment of severe cytomegalovirus infection in allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984924

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984924

Prophylaxis and treatment of cytomegalovirus infections in the bone marrow transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984924

(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984924

Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984924

Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984924

Efficacy of phosphonylmethoxyalkyl derivatives of adenine in experimental herpes simplex virus and vaccinia virus infections in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984924

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine in various models of herpes simplex virus infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984924

Novel sulfated polysaccharides: dissociation of anti-human immunodeficiency virus activity from antithrombin activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984924

Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984924

Dextran sulfate is poorly absorbed after oral administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01984924

Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).

21 January 2018

1 reference

12 December 2020

Treatment of cytomegalovirus disease

1 reference

12 December 2020

Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines

1 reference

12 December 2020

Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation

1 reference

12 December 2020

A novel selective broad-spectrum anti-DNA virus agent

1 reference

12 December 2020

Ganciclovir in the treatment of cytomegalovirus pneumonitis in bone marrow transplant recipients

1 reference

12 December 2020

Evolution of therapy for cytomegalovirus infection

1 reference

12 December 2020

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

1 reference

12 December 2020

Anti-retrovirus activity of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) in vivo increases when it is less frequently administered

1 reference

12 December 2020

Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique

1 reference

12 December 2020

Use of ganciclovir to treat serious cytomegalovirus infections in patients with AIDS

1 reference

12 December 2020

Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts

1 reference

12 December 2020

Treatment of acquired immune deficiency syndrome (AIDS)-related pneumonitis with foscarnet: a double-blind placebo controlled study

1 reference

12 December 2020

Sensitivity of clinical isolates of human cytomegalovirus to 9-(1,3-dihydroxy-2-propoxymethyl)guanine

1 reference

12 December 2020

A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphate

1 reference

12 December 2020

Gastrointestinal cytomegalovirus infection in heart and heart-lung transplant recipients

1 reference

12 December 2020

Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitro

1 reference

12 December 2020

Detection of immediate early, early and late antigens of human cytomegalovirus by flow cytometry

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01984924

1 reference

Dimensions Publication ID

6 October 2017

1047578182

0 references

1 reference